Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaleb Michaud

Showing results (151-160 of 273) with videos related to

Pageof 28
Sort By:
Arthritis Care & Research|April 24, 2023
Clinical Features Associated With Rate of Fractures in Patients With Systemic Sclerosis: A US Cohort StudyBliss Rogers, Sina Famenini, Jamie Perin, et al.
ACR Open Rheumatology|January 17, 2020
Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus ErythematosusPatricia Katz, Sofia Pedro, Evo Alemao, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Arthritis Care & Research|August 2, 2021
Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness RegistryBryant R England, Huifeng Yun, Lang Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 15, 2015
Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisMohammad Movahedi, Marie-Eve Beauchamp, Michal Abrahamowicz, et al.
Advances in Therapy|April 21, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic DrugsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Arthritis Care & Research|August 20, 2020
Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth VisitsBryant R England, Claire E H Barber, Martin Bergman, et al.
The Journal of Rheumatology|October 15, 2025
Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody StatusKristin Wipfler, Joshua F Baker, Harlan Sayles, et al.
Clinical and Experimental Rheumatology|February 6, 2019
Current and early life weight and associations with mortality in rheumatoid arthritisJoshua F Baker, Andrew Stokes, Ted R Mikuls, et al.
ACR Open Rheumatology|September 13, 2020
Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid ArthritisLuke W Desilet, Bryant R England, Kaleb Michaud, et al.
Pageof 28

Showing results (151-160 of 273) with videos related to

Sort By:
Pageof 28
Arthritis Care & Research|April 24, 2023
Clinical Features Associated With Rate of Fractures in Patients With Systemic Sclerosis: A US Cohort StudyBliss Rogers, Sina Famenini, Jamie Perin, et al.
ACR Open Rheumatology|January 17, 2020
Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus ErythematosusPatricia Katz, Sofia Pedro, Evo Alemao, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Arthritis Care & Research|August 2, 2021
Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness RegistryBryant R England, Huifeng Yun, Lang Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 15, 2015
Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisMohammad Movahedi, Marie-Eve Beauchamp, Michal Abrahamowicz, et al.
Advances in Therapy|April 21, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic DrugsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.
Arthritis Care & Research|August 20, 2020
Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth VisitsBryant R England, Claire E H Barber, Martin Bergman, et al.
The Journal of Rheumatology|October 15, 2025
Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody StatusKristin Wipfler, Joshua F Baker, Harlan Sayles, et al.
Clinical and Experimental Rheumatology|February 6, 2019
Current and early life weight and associations with mortality in rheumatoid arthritisJoshua F Baker, Andrew Stokes, Ted R Mikuls, et al.
ACR Open Rheumatology|September 13, 2020
Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid ArthritisLuke W Desilet, Bryant R England, Kaleb Michaud, et al.
Pageof 28